Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


China Yingxia International in India

This article was originally published in The Tan Sheet

Executive Summary

The developer and manufacturer of organic nutritional food products, supplements and personal care products announces Jan. 17 its establishment of a wholly-owned subsidiary in India. "The establishment of a subsidiary in India is just one small step and much work still needs to be done before the Indian market has an impact on sales and earnings," Harbin, China-based firm's Chairman Jiao Yingxia says in a release...

You may also be interested in...

EU Biosimilar Filings, Opinions And Approvals

A list of EU biosimilar filings, CHMP opinions and EU marketing authorizations, including details of the biosimilar company, the brand name/INN, indication(s), the reference product/company, and the date and type of event.

Executives On The Move: Alligator Bioscience Appoints New Chief Business Officer

American Injectables gets a new CEO, while Hemostemix names a new chief medical officer.

Global Coalition Urges Regulatory Convergence On COVID-19 Vaccines

Mutual recognition of approvals and simplified rules on labeling could help to make COVID-19 vaccines more accessible to populations around the world. 





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts